Nova Pharma Solutions Berhad is a Malaysia-based company, which is principally engaged in the business of provision of technical documentation, validation and project execution in the pharmaceutical and biological industries. The Company operates through four segments. Design fee segment comprise of conceptual designs, which include user requirement specification, capacity analysis and process scheduling with detailed costing, list of deliverables, details specification of various equipment and processes, as well as authorities' compliance requirements. Post design fee segment comprise of tendering and procurement support, as well as construction of plant. Other support fee segment comprises of services to assist customer in the manufacturing practice document review and gap analysis and assessment. EPCC comprise of works and services pertaining to engineering and /or procurement and /or construction and /or commissioning for advanced technology facilities.

To be entitled for any of the above, you need to purchase the shares one trading day before the ex-Date. You will not be entitled for the above if you purchase the shares on or after the ex-Date.

On ex-Date, the price will be adjusted to reflect the theoretical market price of the stock after the entitlement. You can sell the shares on / after ex-Date and still be entitled to the corporate exercise. The key is to purchase the shares before ex-Date.

No application is needed. Shareholders that fulfill the requirement above will receive the dividend in their registered bank account on the payment date automatically.